Mushroom poisoning epidemiology in the United States

被引:85
作者
Brandenburg, William E. [1 ,2 ]
Ward, Karlee J. [3 ]
机构
[1] RTT Caldwell, Family Med Residency Idaho, 777 N Raymond St, Boise, ID 83704 USA
[2] West Valley Med Ctr, 1717 Arlington Ave, Caldwell, ID 83605 USA
[3] St Lukes Hosp, Pediat Intens Care Unit, 190 E Bannock St, Boise, ID 83712 USA
关键词
Cyclopeptide; monomethylhyrazine; mycotoxin; National Poison Data System; psilocybin; AMERICAN-ASSOCIATION; CLASSIFICATION;
D O I
10.1080/00275514.2018.1479561
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Ingestion ofwild and potentially toxic mushrooms is common in the United States and many other parts of the world. US poison centers have been logging cases of mushroom exposure in The National Poison Data System (NPDS) annual publications for over 30 years. This study compiles and analyzes US mushroom exposures as reported by the NPDS from 1999 to 2016. Over the last 18 years, 133 700 cases (7428/year) of mushroom exposure, mostly by ingestion, have been reported. Cases are most frequently unintentional (83%, P < 0.001); cause no or only minor harm(86%, P < 0.001); and in children < 6 years old (62%, P < 0.001). Approximately 704 (39/year) exposures have resulted in major harm. Fiftytwo (2.9/year) fatalities have been reported, mostly from cyclopeptide (68-89%)-producingmushrooms ingested by older adults unintentionally. The vast majority of reported ingestions resulted in no or minor harm, although some groups of mushroom toxins or irritants, such as cyclopepides, ibotenic acid, and monomethylhydrazine, have been deadly. Misidentification of edible mushroom species appears to be the most common cause and may be preventable through education.
引用
收藏
页码:637 / 641
页数:5
相关论文
共 36 条
  • [1] Trends in types of calls managed by US poison centers 2000-2015
    Anderson, Bruce D.
    Seung, Hyunuk
    Klein-Schwartz, Wendy
    [J]. CLINICAL TOXICOLOGY, 2018, 56 (07) : 640 - 645
  • [2] Arora D., 1986, Mushrooms Demystified: A Comprehensive Guide to The Fleshy Fungi, P4
  • [3] Mycotoxins revisited: Part I
    Berger, KJ
    Guss, DA
    [J]. JOURNAL OF EMERGENCY MEDICINE, 2005, 28 (01) : 53 - 62
  • [4] Mycotoxins revisited: Part II
    Berger, KJ
    Guss, DA
    [J]. JOURNAL OF EMERGENCY MEDICINE, 2005, 28 (02) : 175 - 183
  • [5] Beug MW., 2017, MUSHROOM POISONING N
  • [6] Biologically Active Secondary Metabolites from the Fungi
    Bills, Gerald F.
    Gloer, James B.
    [J]. MICROBIOLOGY SPECTRUM, 2016, 4 (06):
  • [7] 2006 annual report of the American association of poison control centers' National Poison Data System (NPDS)
    Bronstein, Alvin C.
    Spyker, Daniel A.
    Cantilena, Louis R., Jr.
    Green, Jody
    Rumack, Barry H.
    Heard, Stuart E.
    [J]. CLINICAL TOXICOLOGY, 2007, 45 (08) : 815 - 917
  • [8] 2011 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report
    Bronstein, Alvin C.
    Spyker, Daniel A.
    Cantilena, Louis R., Jr.
    Rumack, Barry H.
    Dart, Richard C.
    [J]. CLINICAL TOXICOLOGY, 2012, 50 (10) : 911 - 1164
  • [9] 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report
    Bronstein, Alvin C.
    Spyker, Daniel A.
    Cantilena, Louis R.
    Green, Jody L.
    Rumack, Barry H.
    Dart, Richard C.
    [J]. CLINICAL TOXICOLOGY, 2011, 49 (10) : 910 - 941
  • [10] 2009 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th Annual Report
    Bronstein, Alvin C.
    Spyker, Daniel A.
    Cantilena, Louis R., Jr.
    Green, Jody L.
    Rumack, Barry H.
    Giffin, Sandra L.
    [J]. CLINICAL TOXICOLOGY, 2010, 48 (10) : 979 - 1178